Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Does the Prevalence of Hearing Impairment Differ in Children With Congenital Hypothyroidism and Healthy Children in Isfahan?



Salek M1 ; Hashemipour M1 ; Hashemi M1 ; Hajrahimi M2 ; Sadeghi S2 ; Farajzadegan Z1 ; Hovsepian S2 ; Hadian R2
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Isfahan University of Medical Sciences, Iran
  2. 2. Isfahan Endocrine Research Center, Iran

Source: Journal of Isfahan Medical School Published:2007

Abstract

Background: Congenital hypothyroidism (CH) has a considerably high prevalence in our country, and without early treatment, it would lead to irreversible sequelae like hearing impairment. This study was aimed to investigate the prevalence of hearing loss in children with CH in comparison with healthy children. Methods: This case-control study was conducted in two groups of children; the case group consisted of 94 children with CH aged more than 4 months under follow up in Isfahan endocrine research center; the control group included 450 healthy infants underwent routine neonatal hearing screening in a private hospital. First, Otto Acoustic Emission (OAE) test was performed, and in the case of being abnormal, then auditory brain stem response (ABR) test was conducted. Children with abnormal ABR were considered to have hearing impairment. Findings: The prevalence of hearing impairment was not significantly different between children with CH and controls (3.2% vs. 0.2%, respectively; p>0.05). The mean age of beginning the treatment for CH was not significantly different between children with or without hearing impairment (13.6±8.3 vs. 16.4±8.05 days, respectively; p>0.05).The mean T4 and TSH was not significantly different between children with CH with and without hearing impairment (5.6±4.2 mg/dl and 133.7±80.3 MIU/l vs. 6.2±3.7 mg/dl and 116.5±92.1 MIU/l, respectively; p>0.05). Conclusion: We did not document any difference in the prevalence of hearing impairment in children with CH and controls; this finding might be because of limited number of subjects studied and the short duration of follow up. There was no difference neither between the age of beginning the treatment for CH and hearing impairment, nor between the mean T4 and TSH at birth and hearing impairment. Hearing loss has no relationship with age at treatment onset and primary T4 and TSH level at diagnoses. © 2007, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Other Related Docs
13. Congenital Hypothyroidism; Is There Any Familial Component?, Journal of Isfahan Medical School (2009)
15. Hearing Abnormality in Neonate Intensive Care Unit (Nicu), Yazd-Iran, International Journal of Pediatrics (2014)
19. Prevalence of Deafness and Hearing Screening in Newborns in Isfahan, Journal of Research in Medical Sciences (2012)
23. The Role of Ultrasonography in Primary Congenital Hypothyroidism, Journal of Research in Medical Sciences (2011)
29. Different Aspects of Kidney Function in Well-Controlled Congenital Hypothyroidism, JCRPE Journal of Clinical Research in Pediatric Endocrinology (2012)
32. Guideline for the Treatment of Hypothyroidism in Prematurity, International Journal of Preventive Medicine (2021)
33. Spatial Distribution of Congenital Hypothyroidism, Archives of Iranian Medicine (2021)